Novanta Inc (STU:1GSN) Stock Price, Trades & News

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Financial Strength

8/10

Name	Current	Vs Industry
Cash-To-Debt	1.34
Equity-to-Asset	0.73
Debt-to-Equity	0.22
Debt-to-EBITDA	1.62
Interest Coverage	6.61
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	7.87	Distress Grey Safe
Beneish M-Score	-2.38	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

7/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	3.7
	3-Year EBITDA Growth Rate	2.8
	3-Year EPS without NRI Growth Rate	2.3
	3-Year FCF Growth Rate	-12
	3-Year Book Growth Rate	31.6

Momentum Rank

10/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	24.64
	9-Day RSI	35.62
	14-Day RSI	42.22
	3-1 Month Momentum %	29.81
	6-1 Month Momentum %	22.73
	12-1 Month Momentum %	20.54

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	3.56
	Quick Ratio	2.69
	Cash Ratio	1.76
	Days Inventory	113.96
	Days Sales Outstanding	62.09
	Days Payable	60.28

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Shareholder Yield %	2.65

Profitability Rank

9/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	44.23
	Operating Margin %	11.63
	Net Margin %	5.35
	EBITDA Margin %	17.85
	FCF Margin %	6.85
	OCF Margin %	8.39
	ROE %	5.37
	ROA %	3.35
	ROIC %	7.11
	3-Year ROIIC %	-0.44
	ROC (Joel Greenblatt) %	32.25
	ROCE %	8.28
	Years of Profitability over Past 10-Year	10
	Moat Score	6
	Tariff Resilience Score	6

GF Value Rank

9/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	107.67
	Forward PE Ratio	44.97
	PE Ratio without NRI	51.15
	Shiller PE Ratio	85.59
	Price-to-Owner-Earnings	207.53
	PEG Ratio	4.26
	PS Ratio	5.6
	PB Ratio	4.04
	Price-to-Tangible-Book	10.64
	Price-to-Free-Cash-Flow	86.04
	Price-to-Operating-Cash-Flow	69.56
	EV-to-EBIT	44.45
	EV-to-EBITDA	28.95
	EV-to-Revenue	5.17
	EV-to-FCF	75.82
	Price-to-GF-Value	0.97
	Price-to-Projected-FCF	2.63
	Price-to-DCF (Earnings Based)	2.83
	Price-to-DCF (FCF Based)	5.85
	Price-to-Median-PS-Value	1.07
	Price-to-Peter-Lynch-Fair-Value	4.87
	Price-to-Graham-Number	4.92
	Price-to-Net-Current-Asset-Value	17.71
	Earnings Yield (Greenblatt) %	2.25
	FCF Yield %	1.29
	Forward Rate of Return (Yacktman) %	12.19

Financials (Next Earnings Date:2026-08-05 Est.)

Annual Quarterly TTM

STU:1GSN's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Novanta Inc Operating Data

Annual Quarterly

STU:1GSN's Complete Operating Data

No operating data available for Novanta Inc.

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Novanta Inc Executives

Details

GF Value™: €134.1

STU:1GSN

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with 1GSN. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	863.692
	EPS (TTM) (€)	1.185
	Beta	1.3653
	3-Year Sharpe Ratio	-0.08
	3-Year Sortino Ratio	-0.12
	Volatility %	47.32
	14-Day RSI	42.22
	14-Day ATR (€)	5.136061
	20-Day SMA (€)	137.1
	12-1 Month Momentum %	20.54
	52-Week Range (€)	84.5 - 147
	Shares Outstanding (Mil)	35.61

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Novanta Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Novanta Inc Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-11-04 08:30	In 119 days
Third quarter earnings results for 2026	2026-11-04	In 118 days
Second quarter earnings conference call for 2026	2026-08-05 10:00	In 28 days
Second quarter earnings results for 2026	2026-08-05	In 27 days
General meeting for 2026	2026-05-28 15:00	138.00 (-1.43%)
First quarter earnings conference call for 2026	2026-05-12 08:00	118.00 (+0.85%)
First quarter earnings results for 2026	2026-05-11	117.00 (+0.86%)
Fourth quarter earnings conference call for 2025	2026-02-24 08:00	120.00 (-1.64%)
Fourth quarter earnings results for 2025	2026-02-24	120.00 (-1.64%)
Annual report for 2025	2026-02-23	123.00 (+0.00%)

Show

Entries

Novanta Inc Frequently Asked Questions

What is Novanta Inc(STU:1GSN)'s stock price today?

The current price of STU:1GSN is €130.00. The 52 week high of STU:1GSN is €147.00 and 52 week low is €84.50.

When is next earnings date of Novanta Inc(STU:1GSN)?

The next earnings date of Novanta Inc(STU:1GSN) is 2026-08-05 Est..

Does Novanta Inc(STU:1GSN) pay dividends? If so, how much?

Novanta Inc(STU:1GSN) does not pay dividend.

Press Release

	Subject	Date
	Novanta to Present at the CJS Securities 26th Annual New Ideas Summer Conference on Thursday, July 9, 2026	2026-06-22
	Novanta Inc. Announces $300 Million Private Placement	2026-06-09
	Novanta Inc. Announces Acquisition of Riverpoint Medical	2026-06-09
	Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026	2026-05-15
	Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call	2026-04-14
	Novanta Joins NVIDIA Halos AI Systems Inspection Lab	2026-03-16
	Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025	2026-02-23
	Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026	2026-01-22
	Novanta to Present at the CJS Securities 26th Annual New Ideas for the New Year Investor Conference on Wednesday, January 14, 2026	2025-12-18
	Novanta to Present at the J.P. Morgan 44th Annual Healthcare Conference on Wednesday, January 14, 2026	2025-12-15

10/Page

Articles on Novanta Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.